• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与患者不良反应漏报相关的因素:一项系统评价。

Factors associated with underreporting of adverse drug reactions by patients: a systematic review.

机构信息

Faculdade de Farmácia da Universidade de Lisboa, Lisbon, Portugal.

Facultad de Medicina y Odontología de la Universidad de Santiago de Compostela, A Coruña, Galicia, Spain.

出版信息

Int J Clin Pharm. 2023 Dec;45(6):1349-1358. doi: 10.1007/s11096-023-01592-y. Epub 2023 May 29.

DOI:10.1007/s11096-023-01592-y
PMID:37247159
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10682061/
Abstract

BACKGROUND

Spontaneous reporting is the most used method to monitor post-marketing safety information. Although patient involvement in spontaneous reporting has increased overtime, little is known about factors associated with patients' adverse drug reaction (ADR) reporting.

AIM

To identify and assess the sociodemographic characteristics, attitudes and knowledge that influence spontaneous reporting and the reasons associated with ADR underreporting by patients.

METHOD

A systematic review was conducted according to PRISMA guidelines. A search on the MEDLINE and EMBASE scientific databases was performed to retrieve studies published between 1 January 2006 and 1 November 2022. Studies were included if they addressed knowledge and attitudes associated with ADR underreporting.

RESULTS

A total of 2512 citations were identified, of which 13 studies were included. Sociodemographic characteristics were frequently identified with ADR reporting in 6 studies, being age (3/13) and level of education (3/13) the most often reported. Older age groups (2/13) and individuals with higher level of education (3/13) were more likely to report ADRs. Underreporting was shown to be motivated by reasons related to knowledge, attitudes, and excuses. Ignorance (10/13), complacency (6/13), and lethargy (6/13) were the most frequent reasons for not reporting.

CONCLUSION

This study highlighted the scarcity of research conducted with the aim of assessing ADR underreporting by patients. Knowledge, attitudes, and excuses were commonly observed in the decision to report ADRs. These motives are characteristics that can be changed; hence strategies must be designed to raise awareness, continually educate, and empower this population to change the paradigm of underreporting.

摘要

背景

自发报告是监测上市后安全性信息最常用的方法。尽管患者参与自发报告的比例随着时间的推移有所增加,但对于与患者药物不良反应(ADR)报告相关的因素知之甚少。

目的

确定并评估影响自发报告的社会人口统计学特征、态度和知识,以及患者 ADR 漏报的相关原因。

方法

根据 PRISMA 指南进行系统综述。在 MEDLINE 和 EMBASE 科学数据库上进行检索,以获取 2006 年 1 月 1 日至 2022 年 11 月 1 日期间发表的研究。如果研究涉及与 ADR 漏报相关的知识和态度,则将其纳入。

结果

共确定了 2512 条引用,其中包括 13 项研究。6 项研究频繁发现与 ADR 报告相关的社会人口统计学特征,其中年龄(3/13)和教育程度(3/13)是最常报告的特征。年龄较大的群体(2/13)和教育程度较高的个体(3/13)更有可能报告 ADR。漏报的原因与知识、态度和借口有关。不报告的最常见原因是无知(10/13)、自满(6/13)和懒惰(6/13)。

结论

本研究强调了针对患者 ADR 漏报情况进行评估的研究相对较少。知识、态度和借口是决定报告 ADR 的常见因素。这些动机是可以改变的特征;因此,必须设计策略来提高认识、持续教育,并赋予这一人群权力,以改变漏报的模式。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b27/10682061/b8d47557e375/11096_2023_1592_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b27/10682061/b8d47557e375/11096_2023_1592_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b27/10682061/b8d47557e375/11096_2023_1592_Fig1_HTML.jpg

相似文献

1
Factors associated with underreporting of adverse drug reactions by patients: a systematic review.与患者不良反应漏报相关的因素:一项系统评价。
Int J Clin Pharm. 2023 Dec;45(6):1349-1358. doi: 10.1007/s11096-023-01592-y. Epub 2023 May 29.
2
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
3
How to promote adverse drug reaction reports using information systems - a systematic review and meta-analysis.如何利用信息系统促进药品不良反应报告——一项系统评价与荟萃分析
BMC Med Inform Decis Mak. 2016 Mar 1;16:27. doi: 10.1186/s12911-016-0265-8.
4
Patient versus healthcare professional spontaneous adverse drug reaction reporting: a systematic review.患者与医疗保健专业人员自发药物不良反应报告:系统评价。
Drug Saf. 2012 Oct 1;35(10):807-18. doi: 10.1007/BF03261977.
5
Determinants of under-reporting of adverse drug reactions: a systematic review.药品不良反应报告不足的决定因素:一项系统综述
Drug Saf. 2009;32(1):19-31. doi: 10.2165/00002018-200932010-00002.
6
The value of patient reporting to the pharmacovigilance system: a systematic review.患者向药物警戒系统报告的价值:一项系统评价
Br J Clin Pharmacol. 2017 Feb;83(2):227-246. doi: 10.1111/bcp.13098. Epub 2016 Oct 12.
7
The educational effects of portfolios on undergraduate student learning: a Best Evidence Medical Education (BEME) systematic review. BEME Guide No. 11.档案袋对本科学生学习的教育效果:最佳证据医学教育(BEME)系统评价。BEME指南第11号。
Med Teach. 2009 Apr;31(4):282-98. doi: 10.1080/01421590902889897.
8
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
9
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.抗抑郁药治疗成人慢性疼痛的疼痛管理:一项网络荟萃分析。
Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948.
10
Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.吸入装置在哮喘和慢性阻塞性气道疾病中的有效性比较:文献系统评价
Health Technol Assess. 2001;5(26):1-149. doi: 10.3310/hta5260.

引用本文的文献

1
Identifying Predictors of Serious Adverse Events in Antidepressant Treatment from a Decade-Long Nationwide Pharmacovigilance Study: Impact of Dementia and Parkinson's Disease Treatment.一项长达十年的全国性药物警戒研究中抗抑郁治疗严重不良事件预测因素的识别:痴呆症和帕金森病治疗的影响
Medicina (Kaunas). 2025 Jun 17;61(6):1103. doi: 10.3390/medicina61061103.
2
Lamotrigine Therapy: Relation Between Treatment of Bipolar Affective Disorder and Incidence of Stevens-Johnson Syndrome-A Narrative Review of the Existing Literature.拉莫三嗪治疗:双相情感障碍治疗与史蒂文斯-约翰逊综合征发病率之间的关系——现有文献的叙述性综述
J Clin Med. 2025 Jun 10;14(12):4103. doi: 10.3390/jcm14124103.
3

本文引用的文献

1
A cross-sectional study: comparison of public perceptions of adverse drug reaction reporting and monitoring in eastern and western China.一项横断面研究:比较中东部和中西部地区公众对药品不良反应报告和监测的认知。
BMC Health Serv Res. 2022 Mar 8;22(1):318. doi: 10.1186/s12913-022-07720-0.
2
The Importance of Direct Patient Reporting of Adverse Drug Reactions in the Safety Monitoring Process.直接报告药物不良反应对安全性监测过程的重要性。
Int J Environ Res Public Health. 2021 Dec 31;19(1):413. doi: 10.3390/ijerph19010413.
3
Parental reporting of adverse drug reactions in South Africa: An online survey.
Trends in adverse drug reaction reporting in eight selected countries after the implementation of new pharmacovigilance regulation in 2012: a joinpoint regression analysis.
2012年实施新的药物警戒法规后八个选定国家药物不良反应报告的趋势:一项Joinpoint回归分析
Eur J Clin Pharmacol. 2025 Jun 17. doi: 10.1007/s00228-025-03862-2.
4
Impact of in-service training on the knowledge, attitude, and practice of pharmacovigilance in Malawi: a cross-sectional mixed methods study.在职培训对马拉维药物警戒知识、态度和实践的影响:一项横断面混合方法研究。
Malawi Med J. 2024 Oct 16;36(3):163-169. doi: 10.4314/mmj.v36i3.2. eCollection 2024 Oct.
5
Probing Large Language Model Hidden States for Adverse Drug Reaction Knowledge.探索大型语言模型隐藏状态以获取药物不良反应知识
medRxiv. 2025 Feb 12:2025.02.09.25321620. doi: 10.1101/2025.02.09.25321620.
6
Pharmacovigilance for Vaccines Used in Pregnancy: A Gap Analysis From Uganda.孕期使用疫苗的药物警戒:来自乌干达的差距分析
Pediatr Infect Dis J. 2025 Feb 1;44(2S):S123-S129. doi: 10.1097/INF.0000000000004705. Epub 2025 Feb 14.
7
Cutaneous Adverse Drug Reactions Associated with SGLT2 Inhibitors.与SGLT2抑制剂相关的皮肤药物不良反应
J Clin Med. 2024 Dec 31;14(1):188. doi: 10.3390/jcm14010188.
8
Cardiovascular and Metabolic Adverse Events of Endocrine Therapies in Women with Breast Cancer: A Disproportionality Analysis of Reports in the FDA Adverse Event Reporting System.乳腺癌女性内分泌治疗的心血管和代谢不良事件:FDA不良事件报告系统中报告的不成比例分析
Cancer Med. 2025 Jan;14(1):e70548. doi: 10.1002/cam4.70548.
9
Consumer views on the use of digital tools for reporting adverse drug reactions: a cross-sectional study.消费者对使用数字工具报告药物不良反应的看法:一项横断面研究。
Int J Clin Pharm. 2025 Apr;47(2):423-434. doi: 10.1007/s11096-024-01847-2. Epub 2024 Dec 19.
10
The Use of Botulinum Toxin Type A and the Occurrence of Anaphylaxis: A Descriptive Analysis of Data from the European Spontaneous Reporting System.A型肉毒杆菌毒素的使用与过敏反应的发生:来自欧洲自发报告系统的数据描述性分析
Aesthetic Plast Surg. 2025 Apr;49(7):2032-2039. doi: 10.1007/s00266-024-04564-3. Epub 2024 Dec 5.
南非的药物不良反应家长报告:一项在线调查。
Afr J Prim Health Care Fam Med. 2021 Sep 29;13(1):e1-e8. doi: 10.4102/phcfm.v13i1.2880.
4
Health-care Professionals' Knowledge and Perception of Adverse Drug Reaction Reporting and Pharmacovigilance in a Tertiary Care Teaching Hospital of Nepal.尼泊尔一家三级护理教学医院中医疗保健专业人员对药品不良反应报告和药物警戒的知识与认知
Hosp Pharm. 2021 Jun;56(3):178-186. doi: 10.1177/0018578719883796. Epub 2019 Nov 5.
5
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
6
Adverse Drug Reaction Reporting by Patients in 12 European Countries.患者在 12 个欧洲国家的药物不良反应报告。
Int J Environ Res Public Health. 2021 Feb 5;18(4):1507. doi: 10.3390/ijerph18041507.
7
What are the patients' and health care professionals' understanding and behaviors towards adverse drug reaction reporting and additional monitoring?患者和医疗保健专业人员对药物不良反应报告和额外监测的理解和行为是什么?
Pharmacoepidemiol Drug Saf. 2021 Mar;30(3):334-341. doi: 10.1002/pds.5162. Epub 2020 Nov 8.
8
A cross-sectional survey of knowledge, attitude, and willingness to engage in spontaneous reporting of adverse drug reactions by Korean consumers.一项横断面调查研究,旨在了解韩国消费者对药物不良反应自发报告的知识、态度和意愿。
BMC Public Health. 2020 Oct 8;20(1):1527. doi: 10.1186/s12889-020-09635-z.
9
Adverse Drug Reaction Reporting in Ethiopia: Systematic Review.在埃塞俄比亚的药物不良反应报告:系统评价。
Biomed Res Int. 2020 Aug 10;2020:8569314. doi: 10.1155/2020/8569314. eCollection 2020.
10
Post marketing surveillance of suspected adverse drug reactions through spontaneous reporting: current status, challenges and the future.通过自发报告对疑似药品不良反应进行上市后监测:现状、挑战与未来。
Ther Adv Drug Saf. 2020 Aug 10;11:2042098620938595. doi: 10.1177/2042098620938595. eCollection 2020.